FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099551 [Registered on: 19/12/2025] Trial Registered Prospectively
Last Modified On: 18/12/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Single Arm Study 
Public Title of Study   Treatment of Throat Irritation with Unani Medicine Qurse-Tabasheer Mulaiyin. 
Scientific Title of Study   A single-arm, multicentre, clinical validation study to Evaluate the Safety and Efficacy of a Unani Pharmacopoeial formulation, Qurs-e-Tabasheer Mulaiyin in Khushanat-i-Halq (Irritation of Throat) 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
KH/IT/QTM/CLNVAL/CCRUM/23-24, Version No-02, 13.06.2025  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr N Zaheer Ahmed 
Designation  Director General 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Room No. 502, Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri South West

South West
DELHI
110058
India 
Phone  01128525715  
Fax    
Email  drnzaheer@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Younis I Munshi 
Designation  Deputy Director General 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Room No. 507, Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri South West India

South West
DELHI
110058
India 
Phone  09419086700  
Fax    
Email  younismunshi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pradeep Kumar 
Designation  Research Officer (Pathology) S-IV  
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Room No. 516, Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri South West DELHI India

South West
DELHI
110058
India 
Phone  08800263300  
Fax    
Email  drpradeepkumar2001@yahoo.com  
 
Source of Monetary or Material Support  
Infrastructural support: 1. National Research Institute of Unani Medicine for Skin Disorders, Opp. E.S.I., Hospital, A.G. Colony Road, Erragadda, Hyderabad–500838 2. Regional Research Institute of Unani Medicine, Chandbali Bypass Road, Near Rural Police Station, Bhadrak–756100  
Monetary Support : Central Council for Research in Unani Medicine (CCRUM),Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058 
 
Primary Sponsor  
Name  Central Council for Research in Unani Medicine  
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mohd Azam  National Research Institute of Unani Medicine for Skin Disorders   Research OPD Room Khushunat-e-Halaq (Irritation of Throat), Opp. E.S.I., Hospital, A.G. Colony Road, Erragadda, Hyderabad – 500838
Hyderabad
TELANGANA 
8707639181

mohdazam.ccrum@ccrum.res.in 
Dr M A waheed  Regional Research Institute of Unani Medicine  Research OPD Room Khushunat-e-Halaq (Irritation of Throat), Chandbali Bypass Road, Near Rural Police Station, Bhadrak–756100
Bhadrak
ORISSA 
9347351749

mawaheed313@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
National Research Institute of Unani Medicine for Skin Disorders, Hyderabad  Approved 
Regional Research Institute of Unani Medicine, Bhadrak  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J02||Acute pharyngitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  Qurs-e-Tabasheer Mulaiyin   2 Tab Twice daily taken orally with lukewarm water for 14 days. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients having Throat irritation with or without any of the following symptoms:
1. Hoarseness of voice
2. Dysphagia
3. Cough
4. Pharyngeal erythema
5. Pain in throat
6. Post nasal drip
 
 
ExclusionCriteria 
Details  1. Known cases of fungal and bacterial pharyngitis.
2. Patients with all classic symptoms of Group A Streptococcal Pharyngitis:
i. Red and swollen tonsils
ii. Tonsillar exudates (white patches /streaks of pus)
iii. Swollen, tender anterior cervical lymph nodes
iv. Absence of cough
3. High grade fever
4.Known cases of Epiglottises.
5. Known cases of Oral candidiasis.
6. Known cases of Herpes simplex.
7.Known cases of Renal or Hepatic or Cardiac ailments.
8.Pregnant and lactating women.

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in the signs and symptoms of Khushunat-e-Halaq (Irritation of Throat). Which will be assessed on the basis of the VAS score.  At baseline, first follow up and at the end of treatment. (i.e., 0, 7th and 14th day) 
 
Secondary Outcome  
Outcome  TimePoints 
Haematological and biochemical investigations for safety assessment i.e.,Haemogram, AEC, LFT, KFT, CRP and Urine R/M.  At baseline, first follow up and at the end of treatment. i.e., 0, 7th and 14th day
 
 
Target Sample Size   Total Sample Size="220"
Sample Size from India="220" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is designed as a multi centric open trial in patients with  Khushunat-e-Halaq (Irritation of Throat)After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically at baseline, first follow up and at the end of treatment. (i.e., 0, 7th and 14th day) This includes subjective assessment of general well being and physical examination. The total duration of treatment will be 14 Days. Laboratory parameters for safety assessment will be conducted at baseline, first follow up and on completion of the protocol therapy (i.e., 0, 7th and 14th day).

Composition of Study drug: Qurs-e-Tabasheer Mulaiyin 

S. No.

Ingredients

Scientific/Botanical name

Quantity

1.       

Tabasheer

Bambusa arundinaceae (Retz.) Roxb.

4 parts

2.       

Turanjabeen

Alhagi pseudalhagi (Bieb.) Desv

3 parts

3.       

Maghz-e-Tukhm-e-Khiyarain

Cucumis sativa seed

1 part

4.       

Maghz-e-Tukhm-e-Kaddu

Laginaria siceraria seed

1 part

5.       

Nishasta-e-Gandum

Triticum sativum

1 part

6.       

Samgh-e-Arabi

Acacia arabica

1 part

7.       

Kateera

Tragacanth gum

1 part

8.       

Khashkhaash Safaid

Papaver somniferum seed

1 part

9.       

Loab-e-Aspaghol

Plantago ovata Forsk

Q.S.


 
Close